These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 38623984)

  • 1. Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
    Kalyaanamoorthy S; Opare SK; Xu X; Ganesan A; Rao PPN
    Curr Alzheimer Res; 2024; 21(1):24-49. PubMed ID: 38623984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation or aggregation: the ramifications of post-translational modifications on tau.
    Park S; Lee JH; Jeon JH; Lee MJ
    BMB Rep; 2018 Jun; 51(6):265-273. PubMed ID: 29661268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
    Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
    Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validated antibody panel for the characterization of tau post-translational modifications.
    Ercan E; Eid S; Weber C; Kowalski A; Bichmann M; Behrendt A; Matthes F; Krauss S; Reinhardt P; Fulle S; Ehrnhoefer DE
    Mol Neurodegener; 2017 Nov; 12(1):87. PubMed ID: 29157277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Marcelli S; Corbo M; Iannuzzi F; Negri L; Blandini F; Nistico R; Feligioni M
    Curr Alzheimer Res; 2018 Feb; 15(4):313-335. PubMed ID: 28474569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.
    Acosta DM; Mancinelli C; Bracken C; Eliezer D
    J Biol Chem; 2022 Jan; 298(1):101442. PubMed ID: 34838590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modifications of tau protein: implications for Alzheimer's disease.
    Martin L; Latypova X; Terro F
    Neurochem Int; 2011 Mar; 58(4):458-71. PubMed ID: 21215781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.
    Haj-Yahya M; Lashuel HA
    J Am Chem Soc; 2018 May; 140(21):6611-6621. PubMed ID: 29684271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease.
    Guan PP; Wang P
    Mol Neurobiol; 2023 Jul; 60(7):3617-3632. PubMed ID: 36877359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.
    Alquezar C; Arya S; Kao AW
    Front Neurol; 2020; 11():595532. PubMed ID: 33488497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational modifications of tau protein.
    Pevalova M; Filipcik P; Novak M; Avila J; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):346-53. PubMed ID: 17262986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.
    Thomas SN; Yang AJ
    Methods Mol Biol; 2017; 1523():161-177. PubMed ID: 27975250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration.
    Zafar S; Fatima SI; Schmitz M; Zerr I
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.
    Ye H; Han Y; Li P; Su Z; Huang Y
    J Mol Neurosci; 2022 Aug; 72(8):1557-1571. PubMed ID: 35325356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease.
    Balmik AA; Chinnathambi S
    Cell Commun Signal; 2021 May; 19(1):51. PubMed ID: 33962636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer's Disease: A Hypothesis.
    Sonawane SK; Chinnathambi S
    J Mol Neurosci; 2018 Aug; 65(4):480-490. PubMed ID: 29982964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.